This inventor holds 1 USPTO granted patent. Top assignee: Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Jieqiong Kang: Innovator in Pharmaceutical Development
Introduction
Jieqiong Kang is a notable inventor based in Shijiazhuang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific proteins for therapeutic applications. His work is crucial in advancing treatments for various diseases.
Latest Patents
Jieqiong Kang holds a patent for a compound related to the targeted ubiquitination degradation of the BRD4 protein. This patent outlines a preparation method and its applications in creating pharmaceutical compositions. The compound can be utilized in the development of drugs aimed at preventing and treating conditions such as cancer, tumors, viral infections, depression, neurological disorders, trauma, age-related cataracts, organ transplant rejection, and autoimmune diseases. He has 1 patent to his name.
Career Highlights
Kang is currently employed at Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. His role at the company allows him to apply his innovative ideas in a practical setting, contributing to the advancement of pharmaceutical technologies.
Collaborations
Some of his notable coworkers include Chuanwu Zhao and Chunhua Jiang. Their collaboration fosters a productive environment for research and development in the pharmaceutical sector.
Conclusion
Jieqiong Kang's work exemplifies the impact of innovation in the pharmaceutical industry. His contributions are paving the way for new treatments that can significantly improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile